Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Leventhal

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
JAAD Case Reports|April 4, 2023
Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approachAlana Deutsch, Natalia Rodriguez, Simon Roy, et al.
European Journal of Dermatology : EJD|April 18, 2017
Generalized lichen nitidus-like eruption in the setting of mogamulizumab and tremelimumabAlvin W Li, Christine J Ko, Jonathan S Leventhal
International Journal of Women'S Dermatology|April 26, 2021
Dermatologic toxicities associated with radiation therapy in women with breast cancerJulie Y Ramseier, Michelle N Ferreira, Jonathan S Leventhal
JAAD International|February 19, 2024
Characterizing skin and soft tissue infections in patients with cancer on systemic oncologic therapy: A single institution retrospective analysis from the outpatient and inpatient oncodermatology serviceJolanta J Pach, Caroline A Nelson, Jonathan S Leventhal
International Journal of Dermatology|June 22, 2018
Necrotic cheek ulcer in a liver transplant patientEmily Coleman, Lauren Levy, Gauri Panse, et al.
American Journal of Clinical Dermatology|February 16, 2024
The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the LiteratureAnnika Belzer, Jolanta J Pach, Kailyn Valido, et al.
Journal of the American Academy of Dermatology|June 12, 2020
Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapiesBrianna Olamiju, Shaman Bhullar, Emily L Coleman, et al.
JAAD Case Reports|May 24, 2024
Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17CKailyn Valido, Michael J Murphy, Jonathan S Leventhal, et al.
Journal of the American Academy of Dermatology|May 9, 2025
The treatment of cutaneous immune-related adverse events from immune checkpoint inhibitors with biologic therapy: A single-institution retrospective study at a tertiary care cancer centerAna B W Greenberg, Kailyn Valido, Matthew Vesely, et al.
Cutis|July 7, 2026
A Solitary Axillary Subcutaneous MassMica C G Williams, Ailish Hanly, Noel Turner, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
JAAD Case Reports|April 4, 2023
Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approachAlana Deutsch, Natalia Rodriguez, Simon Roy, et al.
European Journal of Dermatology : EJD|April 18, 2017
Generalized lichen nitidus-like eruption in the setting of mogamulizumab and tremelimumabAlvin W Li, Christine J Ko, Jonathan S Leventhal
International Journal of Women'S Dermatology|April 26, 2021
Dermatologic toxicities associated with radiation therapy in women with breast cancerJulie Y Ramseier, Michelle N Ferreira, Jonathan S Leventhal
JAAD International|February 19, 2024
Characterizing skin and soft tissue infections in patients with cancer on systemic oncologic therapy: A single institution retrospective analysis from the outpatient and inpatient oncodermatology serviceJolanta J Pach, Caroline A Nelson, Jonathan S Leventhal
International Journal of Dermatology|June 22, 2018
Necrotic cheek ulcer in a liver transplant patientEmily Coleman, Lauren Levy, Gauri Panse, et al.
American Journal of Clinical Dermatology|February 16, 2024
The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the LiteratureAnnika Belzer, Jolanta J Pach, Kailyn Valido, et al.
Journal of the American Academy of Dermatology|June 12, 2020
Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapiesBrianna Olamiju, Shaman Bhullar, Emily L Coleman, et al.
JAAD Case Reports|May 24, 2024
Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17CKailyn Valido, Michael J Murphy, Jonathan S Leventhal, et al.
Journal of the American Academy of Dermatology|May 9, 2025
The treatment of cutaneous immune-related adverse events from immune checkpoint inhibitors with biologic therapy: A single-institution retrospective study at a tertiary care cancer centerAna B W Greenberg, Kailyn Valido, Matthew Vesely, et al.
Cutis|July 7, 2026
A Solitary Axillary Subcutaneous MassMica C G Williams, Ailish Hanly, Noel Turner, et al.
Pageof 8